Status:
COMPLETED
Observational Study of Vision Improvement in Patients With Retinal Disorders
Lead Sponsor:
Optimal Acuity Corporation
Conditions:
Age-related Macular Degeneration
Diabetic Macular Edema
Eligibility:
All Genders
50-100 years
Brief Summary
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders who received corneal treatments by a low vision aid device.
Detailed Description
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders, including age-related macular degeneration and diabetic macular edema, who received corneal t...
Eligibility Criteria
Inclusion
- \- Female or male
- \- Any race
- \- Patient is at least 50 years old
- \- Patient has diagnosed retinal disorder that causes central vision loss in one or both eyes
- \- Treated eyes, at time of treatment, were pseudophakic or phakic with no significant vision loss due to cataract
- \- Patient had moderate to severe baseline vision impairment with CDVA of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s)
- \- Patient CDVA records are available at baseline and at 1m or longer post-Tx times
Exclusion
- 1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study
- \-
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 16 2022
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04693702
Start Date
October 1 2021
End Date
March 16 2022
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bochner Eye Institute
Toronto, Ontario, Canada, M5R 1A9